|
2019 DTT: Longitudinal Analysis of Real‐World Performance of an Implantable Continuous Glucose Sensor Over Multiple Sensor Insertion and Removal Cycles
11/07/2019
|
|
|
2019 DTT: Real-World Data from the First U.S. Commercial Users of an Implantable Continuous Glucose Sensor
08/28/2019
|
|
|
2019 DTT: Real‐World Safety of an Implantable Continuous Glucose Sensor over Multiple Cycles of Use: A Post‐Market Registry Study
08/16/2019
|
|
|
2019 ADA - Post market clinical follow-up (PMCF) registry to demonstrate the long-term safety of the Eversense CGM system
06/08/2019
|
|
|
2019 Diabetes Technology & Therapeutics: A Prospective Multicenter Evaluation of the Accuracy and Safety of an Implanted Continuous Glucose Sensor: The PRECISION Study
05/07/2019
|
|
|
2019 Diabetes Technology and Therapeutics - Clinical Practice Recommendations on the Routine Use of Eversense, the First Long-Term Implantable Continuous Glucose Monitoring System
05/07/2019
|
|
|
2019 AACE - The Eversense CGM System Accuracy and Safety Assessment on the Abdomen Compared to the Upper Arm in a Home Use Setting
04/24/2019
|
|
|
2019 AACE - Evaluation of the Accuracy of an Implantable CGM System with an Updated Glucose Calculation Algorithm
04/24/2019
|
|
|
2019 AACE - Hypoglycemia Performance Evaluation of a New Implantable CGM System
04/24/2019
|
|
|
2019 ATTD - Assessment of the Hypoglycemic Performance of an Implantable CGM System
02/20/2019
|
|